{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T01:37:44Z","timestamp":1774143464200,"version":"3.50.1"},"reference-count":54,"publisher":"American Chemical Society (ACS)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2012,10,25]]},"DOI":"10.1021\/jm3010724","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T13:18:47Z","timestamp":1350393527000},"page":"8770-8789","source":"Crossref","is-referenced-by-count":83,"title":["Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a<\/i>]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor"],"prefix":"10.1021","volume":"55","author":[{"given":"Jose Mar\u00eda","family":"Cid","sequence":"first","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Tresadern","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Vega","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"de Lucas","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Encarnaci\u00f3n","family":"Matesanz","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Iturrino","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Lourdes","family":"Linares","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ar\u00e1nzazu","family":"Garcia","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ignacio","family":"Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor J.","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Oehlrich","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Lavreysen","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Megens","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellah","family":"Ahnaou","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelmus","family":"Drinkenburg","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Mackie","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Pype","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gallacher","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s A.","family":"Trabanco","sequence":"additional","affiliation":[{"name":"Neuroscience Medicinal Chemistry and \u2021Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain"},{"name":"Neuroscience Medicinal Chemistry, \u2225Neuroscience Biology, \u22a5Discovery ADME\/Tox, #Project Management Office, and \u221eCenter of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"Niswender C. M.","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref2\/cit2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","volume":"75","author":"Pilc A.","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref3\/cit3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuron.2010.01.016","volume":"65","author":"L\u00fcscher C.","year":"2010","journal-title":"Neuron"},{"key":"ref4\/cit4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.neuropharm.2011.05.005","volume":"62","author":"Vinson P. N.","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref5\/cit5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coph.2011.10.010","volume":"12","author":"Chiechio S.","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref6\/cit6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1874473710902010083","volume":"2","author":"Foster O. M.","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"key":"ref7\/cit7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152709789824606","volume":"8","author":"Johnson K. A.","year":"2009","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"ref8\/cit8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bst0280297","volume":"28","author":"Watkins J. C.","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"ref9\/cit9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","volume":"179","author":"Kew J. N. C.","year":"2005","journal-title":"Psyhopharmacology"},{"key":"ref10\/cit10","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1073\/pnas.1107775108","volume":"108","author":"Huang S.","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref11\/cit11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0163-7258(03)00038-X","volume":"98","author":"Pin J. P.","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"ref12\/cit12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/138945007779315614","volume":"8","author":"Brauner-Osborne H.","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"ref13\/cit13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","volume":"75","author":"Cartmell J.","year":"2000","journal-title":"J. Neurochem."},{"key":"ref14\/cit14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","volume":"53","author":"Ohishi H.","year":"1993","journal-title":"Neuroscience"},{"key":"ref15\/cit15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cne.20538","volume":"487","author":"Richards G.","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"ref16\/cit16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2007.12.057","volume":"1197","author":"Gu G.","year":"2008","journal-title":"Brain Res."},{"key":"ref17\/cit17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/appi.ajp.2009.08091445","volume":"166","author":"Ghose S.","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"ref18\/cit18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/138161211795049570","volume":"17","author":"Shigeyuki C.","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref19\/cit19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/jm9606756","volume":"40","author":"Monn J. A.","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref20\/cit20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd1630","volume":"4","author":"Swanson C. J.","year":"2005","journal-title":"Nat. Rev. Drug Discovery"},{"key":"ref21\/cit21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.neuropharm.2011.06.007","volume":"62","author":"Fell M. J.","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref22\/cit22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","volume":"13","author":"Patil S. T.","year":"2007","journal-title":"Nat. Med."},{"key":"ref23\/cit23","unstructured":"During the preparation of this manuscript Eli Lilly and Company announced in a press release (August 29, 2012) the decision to stop the clinical studies investigating LY2140023 for the treatment of patients suffering from schizophrenia. The press release mentioned that the decision was made after a recently conducted independent futility analysis concluded that HBBN, the second of Lilly\u2019s two pivotal studies, was unlikely to be positive in its primary efficacy endpoint if enrolled to completion. The decision was not based on any safety signals.https:\/\/investor.lilly.com\/releaseDetail.cfm?ReleaseID=703018."},{"key":"ref24\/cit24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/mol.60.5.881","volume":"60","author":"Pin J. P.","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref25\/cit25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.neuropharm.2008.08.008","volume":"55","author":"Gjoni T.","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref26\/cit26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/pr.109.002501","volume":"63","author":"Urwyler S.","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref27\/cit27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/092986711793979706","volume":"18","author":"Trabanco A. A.","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref28\/cit28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bmcl.2010.12.048","volume":"21","author":"Trabanco A. A.","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref29\/cit29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1039\/C0MD00200C","volume":"2","author":"Trabanco A. A.","year":"2011","journal-title":"Med. Chem. Commum."},{"key":"ref30\/cit30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/cn1000638","volume":"1","author":"Cid J. M.","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"ref31\/cit31","unstructured":"Imogai, H. J.; Cid-Nu\u00f1ez, J. M.; Duvey, G. A. J.; Bolea, C. M.; Nhem, V.; Finn, T. P.; Le Poul, E. C.; Rocher, J.P. F. C.; Lutjens, R. J.Novel Pyridinone Derivatives and Their Preparation, Pharmaceutical Compositions, and Use as Positive Allosteric Modulators of mGluR2-Receptors for Treatment of Various Neurological and Psychiatric Disorders. WO2006030032 A1, 2006."},{"key":"ref32\/cit32","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1021\/jm2016864","volume":"55","author":"Cid J. M.","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref33\/cit33","unstructured":"Cid-Nu\u00f1ez, J. M.; Trabanco-Su\u00e1rez, A. A.; Macdonald, G. J.; Duvey, G. A. J.; Lutjens, R. J.Preparation of 3-Cyano-4-(4-tetrahydropyran-phenyl)pyridin-2-one Derivatives as Positive mGluR2 Receptor Modulators. WO 2008107481 A1, 2008."},{"key":"ref34\/cit34","unstructured":"Imogai, H. I.; Cid-Nu\u00f1ez, J. M.; Andr\u00e9s-Gil, J. I.; Trabanco-Su\u00e1rez, A. A.; Oyarz\u00e1bal-Santamarina, J.; Dautzenberg, F. M.; Macdonald, G. J.; Pullan, S. E.; Lutjens, R. J.; Duvey, G. A. J.; Nhem, V.; Finn, T. P.; Melikyan, G.1,4-Disubstituted 3-Cyanopyridone Derivatives and Their Use as Positive Allosteric Modulators of mGlu2-Receptors and Their Preparation. WO2007104783 A2, 2007."},{"key":"ref35\/cit35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bmcl.2009.11.008","volume":"20","author":"Tresadern G.","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref36\/cit36","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1021\/jm201561r","volume":"55","author":"Trabanco A. A","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref37\/cit37","unstructured":"Cid-Nu\u00f1ez, J. M.; Trabanco-Su\u00e1rez, A. A.; Macdonald, G. J.Preparation of Indole and Benzoxazine Derivatives as Modulators of Metabotropic Glutamate Receptors for Treating Neurological and Psychiatric Disorders. WO 2010060589 A1, 2010."},{"key":"ref38\/cit38","unstructured":"Trabanco-Su\u00e1rez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Cid-Nu\u00f1ez, J. M.Preparation of Imidazopyridine Derivatives for Use as mGluR2 Receptor Modulators. WO2009062676 A2, 2009."},{"key":"ref39\/cit39","unstructured":"Cid-Nu\u00f1ez, J. M.; Oehlrich, D.; Trabanco-Su\u00e1rez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Macdonald, G. J.1,2,4-Triazolo[4,3-a]pyridine Derivatives and Their Use for the Treatment or Prevention of Neurological Disorders. WO2010130424 A1, 2010."},{"key":"ref40\/cit40","unstructured":"Cid-Nu\u00f1ez, J. M.; De Lucas-Olivares, A. I.; Trabanco-Su\u00e1rez, A. A.; Macdonald, G. J.7-Aryl-1,2,4-triazolo[4,3-a]pyridine Derivatives and Their Use as Positive Allosteric Modulators of mGluR2 Receptors. WO2010130423 A1, 2010."},{"key":"ref41\/cit41","unstructured":"Cid-Nu\u00f1ez, J. M.; De Lucas-Olivares, A. I.; Trabanco-Su\u00e1rez, A. A.; Macdonald, G. J.1,2,4-Triazolo[4,3-a]pyridine Derivatives and Their Use as Positive Allosteric Modulators of mGluR2 Receptors. WO2010130422 A1, 2010."},{"key":"ref44\/cit44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","volume":"51","author":"Gleeson M. P.","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref45\/cit45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"Leeson P. D.","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"key":"ref46\/cit46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd2796","volume":"8","author":"Keseru G. M.","year":"2009","journal-title":"Nat. Rev. Drug Discovery"},{"key":"ref47\/cit47","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/jm201388p","volume":"55","author":"Tarcsay A.","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref50\/cit50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.arcmed.2006.07.004","volume":"38","author":"Lopez-Rodriguez F.","year":"2007","journal-title":"Arch. Med. Res."},{"key":"ref51\/cit51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.11.018","volume":"603","author":"Ahnaou A.","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref52\/cit52","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1124\/jpet.104.076547","volume":"312","author":"Feinberg I.","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref53\/cit53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.110.172957","volume":"336","author":"Fell M. J.","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref54\/cit54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2011.07.011","volume":"62","author":"Siok C. J.","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref56\/cit56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130050165","volume":"129","author":"Gleason S. D.","year":"1997","journal-title":"Psychopharmacology"},{"key":"ref58\/cit58","unstructured":"An internal report on the method is available upon request:Beerens, D.In Vitro Bacterial Reverse Mutation (Plate Incorporation) Assay with JNJ42153605-AAA inSalmonella typhimuriumTA98; May 2009."},{"key":"ref59\/cit59","volume-title":"Encyclopaedia of Statistical Science","author":"Tsutakawa R. K.","year":"1982"},{"key":"ref60\/cit60","unstructured":"An internal report on the method is available upon request:Lewi, P. J.; Niemegeers, C. J. E.; Gypen, L. M. J.First Hand Estimation of the Median Effective Dose (ED50) and Its Confidence Interval, Assuming a Linear Log Dose-Response Function. Internal Report N123705\/1; Department of Global Medical and Scientific Information, Johnson & Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium, 1997."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jm3010724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T21:20:54Z","timestamp":1681507254000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/jm3010724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":54,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2012,10,25]]}},"alternative-id":["10.1021\/jm3010724"],"URL":"https:\/\/doi.org\/10.1021\/jm3010724","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}